HCM Acquisition Corp (NASDAQ:HCMA – Get Free Report) was the target of a significant decline in short interest during the month of June. As of June 30th, there was short interest totaling 1,948 shares, a decline of 69.3% from the June 15th total of 6,344 shares. Approximately 0.0% of the company’s shares are sold short. Based on an average daily volume of 16,605 shares, the short-interest ratio is currently 0.1 days.
Analyst Ratings Changes
Separately, Weiss Ratings raised HCM Acquisition from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Monday, June 1st. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the company has a consensus rating of “Sell”.
Read Our Latest Analysis on HCMA
Institutional Inflows and Outflows
HCM Acquisition Stock Down 0.2%
Shares of NASDAQ HCMA traded down $0.02 during trading hours on Tuesday, hitting $10.30. The company’s stock had a trading volume of 437 shares, compared to its average volume of 46,702. HCM Acquisition has a 12 month low of $10.03 and a 12 month high of $10.49. The business has a 50-day simple moving average of $10.24 and a 200-day simple moving average of $10.16.
HCM Acquisition (NASDAQ:HCMA – Get Free Report) last released its quarterly earnings data on Thursday, May 14th. The company reported $0.05 earnings per share for the quarter.
HCM Acquisition Company Profile
HCM Acquisition Corp. is a Delaware‐incorporated special purpose acquisition company (SPAC) that was formed to identify and complete a business combination with one or more target businesses. The company raised capital through its initial public offering and is listed on the Nasdaq under the ticker HCMA. As a blank check vehicle, HCM Acquisition holds its funds in trust until it consummates a qualifying merger, share exchange, asset acquisition or other business combination.
The SPAC is sponsored by affiliates of Healthcare Capital Management LLC, a Los Angeles‐based investment firm with experience in healthcare and life sciences investing.
See Also
- Five stocks we like better than HCM Acquisition
- Why Fastenal’s Latest Drop Could Be Its Biggest Opportunity Yet
- 3 Overlooked Energy ETFs Delivering Strong Returns and Income
- 3 Space Stocks That Could Outshine SpaceX After Its IPO
- JPMorgan’s Q2 Strength Gives the Stock Rally New Support
Receive News & Ratings for HCM Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCM Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.
